ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,275, issued on Nov. 11, was assigned to The Regents of the University of California (Oakland, Calif.).

"Molecularly-initiated, experientially-delivered treatments and systems for practicing same" was invented by Adam Gazzaley (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods comprising presenting a sensory environment to an individual experiencing the effects of a psychoactive agent, monitoring the neural status, the physiological status, or both, of the individual, and presenting a modified sensory environment to the individual based on the monitoring. In certain embodiments, the agent is a psychedelic agent. Accord...